NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

NCT05004415

CompletedPhase 1

Sponsor: Atea Pharmaceuticals, Inc.

Conditions: Healthy Volunteer Study

Interventions: AT-527 (R07496998)

Countries: United States

Mass balance study of AT-527 in Healthy Male Subjects.

Eligibility overview

Sex: MALE

Age: 19 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Minimum body weight of 50 kg and body mass index (BMI) of 18-32 kg/m2
* No clinically significant diseases captured in the medical history or clinically significant findings at screening physical examination.
* A non-vasectomized, male subject must agree to use a condom with spermicide or abstain from sexual intercourse during the study until 90 days after dosing. (No restrictions are required for a vasectomized male provided his vasectomy has been performed 4 months or more prior to dosing. A male who has been vasectomized less than 4 months prior to dosing must follow the same restrictions as a non-vasectomized male).
* Willing to comply with the study requirements and to provide written informed consent

Exclusion Criteria:

* Infected with hepatitis B virus, hepatitis C virus, HIV or COVID-19
* Abuse of alcohol or drugs
* Use of other investigational drugs within 28 days of dosing
* Other clinically significant medical conditions or laboratory abnormalities

Locations (1)

Lincoln, Nebraska, United States